申请人:Marmsater Fredrik P.
公开号:US20100144751A1
公开(公告)日:2010-06-10
Compounds of Formula (I): are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class (3) and class (5) receptor tyrosine kinases. Particular compounds of this invention have also been found to be inhibitors of Pim-1.
化学式(I)的化合物是受体酪氨酸激酶抑制剂,可用于治疗由类(3)和类(5)受体酪氨酸激酶介导的疾病。该发明的特定化合物也被发现是Pim-1的抑制剂。